[go: up one dir, main page]

BR9807043A - Mistura estabilizada que compreende fibrinogênio - Google Patents

Mistura estabilizada que compreende fibrinogênio

Info

Publication number
BR9807043A
BR9807043A BR9807043-6A BR9807043A BR9807043A BR 9807043 A BR9807043 A BR 9807043A BR 9807043 A BR9807043 A BR 9807043A BR 9807043 A BR9807043 A BR 9807043A
Authority
BR
Brazil
Prior art keywords
fibrinogen
solution
stabilized
arginine
lysine
Prior art date
Application number
BR9807043-6A
Other languages
English (en)
Inventor
Israel Nur
Lilliana Bar
Oded Lieberman
Original Assignee
Omrix Biopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP97101569A external-priority patent/EP0856317A1/en
Application filed by Omrix Biopharm Sa filed Critical Omrix Biopharm Sa
Publication of BR9807043A publication Critical patent/BR9807043A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Patente de Invenção: <B>"MISTURA ESTABILIZADORA QUE COMPREENDE FIBRINOGêNIO"<D>. A presente invenção refere-se a uma solução de fibrinogênio estabilizada que contém amostras, em particular uma solução estabilizada do componente biológico atibo (BAC) que é uma solução de proteínas derivadas de plasma sang³íneo que compreende fibrinogênio, ácido tranexâmico e arginina ou lisina e misturas de arginina e lisina, seus sais farmaceuticamente aceitáveis, bem como, opcionalmente, substâncias que formam uma solução tamponada em meio aquoso.
BR9807043-6A 1997-01-31 1998-01-30 Mistura estabilizada que compreende fibrinogênio BR9807043A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97101569A EP0856317A1 (en) 1997-01-31 1997-01-31 A stabilized mixture comprising fibrinogen
PCT/EP1998/000502 WO1998033533A1 (en) 1997-01-31 1998-01-30 A stabilized mixture comprising fibrinogen

Publications (1)

Publication Number Publication Date
BR9807043A true BR9807043A (pt) 2000-03-28

Family

ID=8226433

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9807043-6A BR9807043A (pt) 1997-01-31 1998-01-30 Mistura estabilizada que compreende fibrinogênio

Country Status (13)

Country Link
US (1) US6121232A (pt)
JP (1) JP3825055B2 (pt)
KR (1) KR100345570B1 (pt)
CN (1) CN1182879C (pt)
AT (1) ATE218365T1 (pt)
AU (1) AU724715B2 (pt)
BR (1) BR9807043A (pt)
CA (1) CA2279419A1 (pt)
DE (1) DE69805772T2 (pt)
ES (1) ES2178153T3 (pt)
HU (1) HUP0000908A3 (pt)
NO (1) NO993709L (pt)
PL (1) PL194316B1 (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10025001A1 (de) * 2000-05-22 2001-11-29 Aventis Behring Gmbh Gewebekleber mit verbesserten anti-adhäsiven Eigenschaften
US7276235B2 (en) * 1998-11-18 2007-10-02 Zlb Behring Gmbh Tissue glue with improved antiadhesive properties
CN100345591C (zh) * 2003-08-01 2007-10-31 上海新兴医药股份有限公司 耐干热处理的速溶冻干纤维蛋白原制剂
US7186684B2 (en) * 2003-08-07 2007-03-06 Ethicon, Inc. Hemostatic device containing a protein precipitate
EP1809343B1 (en) * 2004-10-20 2012-08-15 Ethicon, Inc. A reinforced absorbable multilayered hemostatic wound dressing and method of making
US9358318B2 (en) * 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
CN101678086B (zh) * 2007-03-22 2013-07-10 财团法人化学及血清疗法研究所 固体纤维蛋白原制剂
EP2011524A1 (en) 2007-07-02 2009-01-07 Omrix Biopharmaceuticals Ltd. Fibrin glue with a visualization agent
EP2034010A1 (en) 2007-08-30 2009-03-11 Omrix Biopharmaceuticals Ltd. Compositions suitable for repair and/or treatment of injured spinal tissue
ES2438491T3 (es) * 2008-09-22 2014-01-17 Omrix Biopharmaceuticals Ltd. Dispositivo implantable que comprende un sustrato pre-recubierto con fibrina estabilizada
JP5805542B2 (ja) 2009-02-20 2015-11-04 オムリックス・バイオファーマシューティカルズ・リミテッドＯｍｒｉｘ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ． 少なくとも２成分の薬物を投与する装置
CA2787883C (en) 2010-01-28 2019-02-19 Erez Ilan Method for improved fibrin sealing
IL207586A0 (en) 2010-08-12 2010-12-30 Omrix Biopharmaceuticals Ltd A fibrin based therapeutic preparation and use thereof
EP2616550B1 (en) * 2010-09-15 2016-02-10 Debiopharm International SA Method for separating target molecules or particles from fibrinogen-containing samples including blood components
WO2012040595A2 (en) 2010-09-23 2012-03-29 Inflammagen Administration of serine protease inhibitors to the stomach
IL210162A0 (en) 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
IL213375A0 (en) 2011-06-05 2011-07-31 Omrix Biopharmaceuticals Device for spraying fluids in proximity to a surface
WO2013151725A1 (en) 2012-04-05 2013-10-10 The Regents Of The University Of California Regenerative sera cells and mesenchymal stem cells
US10130346B2 (en) 2012-07-24 2018-11-20 Omrix Biopharmaceuticals Ltd. Device and method for the application of a curable fluid composition to a bodily organ
EP2934603A1 (en) 2012-12-20 2015-10-28 Omrix Biopharmaceuticals Ltd. Viral inactivated biological mixture
CN105007829B (zh) 2012-12-30 2018-06-01 奥姆里克斯生物药品有限公司 用于将可固化流体组合物施用到身体器官的一部分的装置和方法
USD754325S1 (en) 2013-06-06 2016-04-19 Omrix Biopharmaceuticals Ltd. Device of a curable fluid composition to a bodily organ
IL230151A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing a polymerization inhibitor
IL230150A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing zymogens
CN112641771B (zh) 2014-03-25 2022-04-15 恒翼生物医药科技(上海)有限公司 用于治疗自身消化的组合物
IL231792A0 (en) 2014-03-27 2014-08-31 Omrix Biopharmaceuticals Ltd Device and method for the preparation and administration of one-component fibrin glue
IL234246A0 (en) 2014-08-21 2014-11-30 Omrix Biopharmaceuticals Ltd Stabilized thrombin
BR112017010250A2 (pt) 2014-11-18 2018-01-02 Omrix Biopharmaceuticals Ltd aparelho para secagem por aspersão e método de uso do mesmo
IL235751A0 (en) 2014-11-18 2015-02-26 Omrix Biopharmaceuticals Ltd An addition to the spray dryer
EP3262409B1 (en) 2015-02-25 2020-03-25 Omrix Biopharmaceuticals Ltd. Method for purifying and quantifying thrombin and its degradation polypeptides
US10159720B2 (en) 2015-12-08 2018-12-25 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, preparation and uses thereof
IL242984A0 (en) 2015-12-08 2016-02-29 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, their preparation and how to use them
IL242924A0 (en) 2015-12-03 2016-04-21 Omrix Biopharmaceuticals Ltd Syringe system for storing and mixing two ingredients
US11202768B2 (en) 2016-01-11 2021-12-21 Leading BioSciences, Inc. Compositions and methods for treating and preventing adhesions and ileus
JP2017176713A (ja) * 2016-03-31 2017-10-05 テルモ株式会社 塗布具
IL247821A0 (en) * 2016-09-14 2017-01-31 Omrix Biopharmaceuticals Ltd Adhesive preparations and their use
CN109081789B (zh) * 2017-06-13 2021-01-01 首都医科大学 氨基正己酰氨基甲环酰氨基正己酰脂肪氨基酸，其合成，活性和应用
IL261190A (en) 2018-08-16 2019-01-31 Omrix Biopharmaceuticals Ltd Stable liquid preparations of thrombin
IL263679A (en) 2018-12-12 2019-03-31 Omrix Biopharmaceuticals Ltd Kits, methods, and compositions for preventing tissue adhesion
WO2020121290A1 (en) 2018-12-12 2020-06-18 Omrix Biopharmaceuticals Ltd. High concentrated protein compositions for preventing tissue adhesion
WO2023042146A1 (en) 2021-09-16 2023-03-23 Ethicon, Inc. Kit for composition for tissue tract sealing
WO2023119277A1 (en) 2021-12-21 2023-06-29 Omrix Biopharmaceuticals Ltd. Highly soluble fibrinogen compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
DK475386D0 (da) * 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen Fremgangsmaade og apparat til fremstilling af biologiske stoffer
US5278189A (en) * 1990-06-04 1994-01-11 Rath Matthias W Prevention and treatment of occlusive cardiovascular disease with ascorbate and substances that inhibit the binding of lipoprotein (A)
EP0691858B1 (en) * 1993-03-30 1999-12-15 Omrix Biopharmaceuticals S.A. Two component fibrin glue

Also Published As

Publication number Publication date
PL334547A1 (en) 2000-03-13
DE69805772T2 (de) 2003-01-30
CN1182879C (zh) 2005-01-05
ATE218365T1 (de) 2002-06-15
ES2178153T3 (es) 2002-12-16
HUP0000908A3 (en) 2001-05-28
AU6214598A (en) 1998-08-25
US6121232A (en) 2000-09-19
CA2279419A1 (en) 1998-08-06
CN1246069A (zh) 2000-03-01
AU724715B2 (en) 2000-09-28
KR20000070634A (ko) 2000-11-25
NO993709L (no) 1999-09-28
KR100345570B1 (ko) 2002-07-26
DE69805772D1 (de) 2002-07-11
JP2000509630A (ja) 2000-08-02
HUP0000908A2 (hu) 2000-08-28
NO993709D0 (no) 1999-07-30
JP3825055B2 (ja) 2006-09-20
PL194316B1 (pl) 2007-05-31

Similar Documents

Publication Publication Date Title
BR9807043A (pt) Mistura estabilizada que compreende fibrinogênio
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
BR9809342A (pt) Composto, composição farmacêutica, e, uso do composto
BRPI0111639B8 (pt) uso de uma molécula de ácido oligodeoxinucléico imunoestimulatório e composição farmacêutica.
EA200000652A1 (ru) Кристаллы глюкагоноподобного пептида 1
BR9908015A (pt) Composições que compreendem vìrus e métodos para concentração de preparações de vìrus
DE69717474D1 (de) Durch cyclische aminosäuren oder cyclische hydroxysäuren substituierte benzamidinderivate und deren verwendung als antikoagulantien
KR870002848A (ko) 항응고물질, 그 제조방법 및 이물질을 유효 성분으로 포함하는 항응고제
BR9813651A (pt) Compostos antipicornavirais e métodos para o seu uso e preparação
DK571186D0 (da) Midler til bestemmelse af peroxidase-aktivitet med stabilisatorer, deres fremstilling og anvendelse
EA200401111A1 (ru) Биполярные соли транс-каротиноидов и их применение
ES2126211T3 (es) Agentes antitromboticos.
DE69836758D1 (de) Apo b, annexin v und tubulin: medizinische und diagnostische verwendung und verwendung zur purifikation von hcv
EA200100583A1 (ru) Композиции, содержащие лактадгерин или его варианты, и способы их использования
ATE131492T1 (de) Synthetische peptide und deren mischungen für den nachweis von hiv-antikörpern
BR9712306A (pt) Processo para preparação de um preparado de igm para aplicação endovenosa
ATE415958T1 (de) Gegen bakterien, mycota und viren wirksame wirkstoffkombinationen auf der basis von dialkylsubstituierten essigsäuren und glycerinalkylethern
BR9804921A (pt) Peptìdeo natriurético atrial (anp) como um aditivo para soluções de diálise peritoneal.
Balcar et al. Na+‐dependent high affinity uptake of l‐glutamate in primary cultures of human fibroblasts isolated from three different types of tissue
BR9811954A (pt) ácidos 3-aril-succinamido-hidroxâmicos, processos para sua produção e preparações farmacêuticas contendo estas substâncias
BR9908861A (pt) Ciclooctadepsipeptìdeos e seu uso para o combate de endoparasitas
DE59813486D1 (de) Verfahren zur Herstellung von Blutplasmaprodukten durch Ausschluss von Spenden mit hohen Parvo-B19-Virenkonzentrationen
DE3889519D1 (de) Glutaminhaltige Peptide, Verfahren zu deren Herstellung und Verwendung.
BR9913991A (pt) Métodos de sub-regulação da resposta imune a proteìnas terapêuticas
ATE242883T1 (de) Verfahren zur bestimmung von blutgerinnungsfaktoren viii und ix

Legal Events

Date Code Title Description
TE Change of address
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A,7A,8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1888 DE 13/03/2007.

B15K Others concerning applications: alteration of classification

Ipc: A61L 24/10 (2006.01), A61K 38/36 (2006.0